AJMC December 5, 2025
Panelists discuss how payer controls and prior authorization policies delay and derail LDL-lowering therapy.
Panelists discuss how payer utilization management and prior authorization processes delay therapy initiation and contribute to high abandonment rates.
The paperwork burden discourages prescribers...







